ExSight
Venture capitalNew York · 1 people tracked
Find your way into ExSight
68 people in our graph share verified history with the ExSight team — schools, employers, funds. One of them is your warm intro.
Fund manager profile
ExSight is a venture fund manager based in New York. SEC filings show 1 venture fund on record, most recently ExSight Fund IV, LLC ($15M offering) filed December 2024.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1Medical Devices ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathValitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical DevicesBerkeley, US
Wesley Jackson(President, Chief Scientific Officer & Member of the Board)inGregory D. Kunst(Chief Executive Officer)Carole H Bellis(Executive Officer)Kevin E Healy(Director)Jackson M Wesley(Executive Officer, Director)
BoardDrew Lanza(Director)in
Co-investorsAngel Physicians FundBerkeley CatalystExSight VenturesFirst Spark Ventures, LlcPandect Bioventures
Frequently asked questions
- Where is ExSight located?
- ExSight is headquartered in New York, US.